Latest Strategy News

Harmoney Corp Limited reported a striking 166% rise in Cash NPAT to $6.1 million for the half-year ended December 2025, driven by robust loan originations and improved interest margins. The company’s scalable model and refinancing efforts underpin its strong financial momentum.

Rio Tinto reported solid 2025 results with an 8% increase in copper equivalent production and disciplined cost management, driving a 9% rise in underlying EBITDA to $25.4 billion. The company marked major project completions and maintained a strong dividend payout.

Talga Group’s application for a major Swedish government grant was declined due to budget constraints, yet the company remains on track with alternative financing to scale its graphite anode production.

F.F.I. Holdings Limited reported a 12% rise in revenue to $33.9 million for the half year ended December 2025, while net profit after tax fell 12.3% to $1.6 million, impacted by one-off costs and a new government lease. The company declared a fully franked interim dividend of 10 cents per share.

Terragen Holdings reports a 23% reduction in half-year net loss amid strategic shifts and completes a $7 million equity raise to accelerate global commercialisation of its biological agricultural products.

Arovella Therapeutics reported a 22% increase in half-year losses to $1.88 million while securing FDA acceptance of its IND application for lead asset ALA-101, paving the way for first-in-human trials.

Raptor Metals has intersected multiple zones of visual copper mineralisation in the initial two holes of its 2,200m diamond drilling program at the Chester Project, validating its resource base and setting the stage for resource growth.

Forrestania Resources has signed a binding ore purchase agreement with Westgold Resources, marking its official transition to gold production with an initial $7.2 million parcel of ore.

3D Energi Limited has offered 41.7 million free attaching options to investors from its October 2025 Placement, aiming to clear trading restrictions despite ongoing ASX suspension and financial challenges.

Cyclopharm Limited is rapidly scaling its US presence for Technegas®, securing new contracts across federal institutions and major health networks in four key regions. The company aims for up to 300 installations by late 2026, boosting recurring revenue streams.

DigitalX Limited reports a robust treasury portfolio valued at A$68.2 million, maintaining significant Bitcoin exposure despite a turbulent January in digital asset markets.

Caravel Minerals has secured non-binding Letters of Interest from Finnish and German export credit agencies, marking a significant step in financing its Caravel Copper Project. This European backing complements a diversified funding strategy as the company moves towards a Final Investment Decision.